Pharmacologic Treatment of Cancer Pain
- 10 October 1996
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 335 (15), 1124-1132
- https://doi.org/10.1056/nejm199610103351507
Abstract
Pain from cancer is a major health care problem.13 Thirty percent of patients with cancer have pain at the time of diagnosis, and 65 to 85 percent have pain when their disease is advanced.2,46 The impact of cancer pain is magnified by the interaction of pain and its treatments with other common cancer symptoms: fatigue, weakness, dyspnea, nausea, constipation, and impaired cognition.4,6 Cancer pain can be effectively treated in 85 to 95 percent of patients with an integrated program of systemic, pharmacologic, and anticancer therapy.7,8 Many of the remaining patients can be helped by the . . .Keywords
This publication has 80 references indexed in Scilit:
- Gabapentin in the management of reflex sympathetic dystrophyJournal of Pain and Symptom Management, 1995
- Unmet Analgesic Needs in Cancer PatientsJournal of Pain and Symptom Management, 1995
- Baclofen as an adjuvant analgesicJournal of Pain and Symptom Management, 1994
- The assessment of constipation in terminal cancer patients admitted to a palliative care unit: A retrospective reviewJournal of Pain and Symptom Management, 1994
- The benzodiazepines as adjuvant analgesicsJournal of Pain and Symptom Management, 1994
- Corticosteroids as adjuvant analgesicsJournal of Pain and Symptom Management, 1994
- New Clinical Experience with TramadolDrugs, 1994
- Intraventricular morphine for intractable pain of advanced cancerJournal of Pain and Symptom Management, 1993
- Character of terminal illness in the advanced cancer patient: Pain and other symptoms during the last four weeks of lifeJournal of Pain and Symptom Management, 1990
- Cancer pain management according to WHO analgesic guidelinesJournal of Pain and Symptom Management, 1990